The Alzheimer’s Disease Neuroimaging Initiative (ADNI) unites researchers with study data as they work to define the progression of Alzheimer’s disease. ADNI researchers collect, validate and utilize data such as MRI and PET images, genetics, cognitive tests, CSF and blood biomarkers as predictors for the disease. Data from the North American ADNI’s study participants, including Alzheimer’s disease patients, mild cognitive impairment subjects and elderly controls, are available from this site.
New data available for Aliquot Count in the LDMS Database
New data available for Aliquot Count in the LDMS Database, version 2014-04-16. The dataset...
New Biomarkers Consortium CSF Proteomics with Multiple Reaction Monitoring Data Now AvailableMore News >
New Biomarkers Consortium data is now available in the ADNI Data Archive. The dataset is...